AN2 Therapeutics
lung disease and growing market opportunity initial indication targeting treatment refractory mac lung disease estimated patients with lung disease in | AN2 Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2022
Slide
11 of 27
Similar slides by AN2 Therapeutics
See diffirences between slides (animation)
Investor Presentation
August 2022
lung disease and growing market opportunity initial indication targeting treatment refractory mac lung disease estimated patients with lung disease in an therapeutics | AN2 Therapeutics
Related slides by other companies
Genelux
Investor Presentation
July 2023
estimated billion dollar plus annual commercial opportunity us ovarian cancer market market non small cell lung in | Genelux
Genelux
Investor Presentation
October 2023
estimated billion dollar plus annual commercial opportunity us ovarian cancer market market non small cell lung in | Genelux
Other recent decks by AN2 Therapeutics
See all presentations (2 decks)
Investor Presentation
August 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io